- DarioHealth Reports First Quarter 2024 Financial and Operating Results
- DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th
- Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes
- Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
- Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
- DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
- DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
- New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications
- DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE
More ▼
Key statistics
On Thursday, DarioHealth Corp (DRIO:NAQ) closed at 1.60, 135.29% above the 52 week low of 0.68 set on Nov 02, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.75 |
---|---|
High | 1.75 |
Low | 1.57 |
Bid | 1.49 |
Offer | 1.60 |
Previous close | 1.74 |
Average volume | 235.67k |
---|---|
Shares outstanding | 29.92m |
Free float | 25.56m |
P/E (TTM) | -- |
Market cap | 52.07m USD |
EPS (TTM) | -2.04 USD |
Data delayed at least 15 minutes, as of May 23 2024 21:00 BST.
More ▼